These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38547773)

  • 1. Emerging function of main RNA methylation modifications in the immune microenvironment of digestive system tumors.
    Zeng Y; Yu T; Lou Z; Chen L; Pan L; Ruan B
    Pathol Res Pract; 2024 Apr; 256():155268. PubMed ID: 38547773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of m6A modification in immune microenvironment of digestive system tumors.
    Li C; Zhu M; Wang J; Wu H; Liu Y; Huang D
    Biomed Pharmacother; 2023 Aug; 164():114953. PubMed ID: 37269812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of RNA methylation modification patterns mediated by m7G, m6A, m5C and m1A regulators in immune microenvironment regulation of Sjögren's syndrome.
    Liu Y; Zhu J; Ding L
    Cell Signal; 2023 Jun; 106():110650. PubMed ID: 36935085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of RNA methylation in tumor immunity and its potential in immunotherapy.
    Li Y; Jin H; Li Q; Shi L; Mao Y; Zhao L
    Mol Cancer; 2024 Jun; 23(1):130. PubMed ID: 38902779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL14‑mediated RNA methylation in digestive system tumors.
    Hu J; Lin H; Wang C; Su Q; Cao B
    Int J Mol Med; 2023 Sep; 52(3):. PubMed ID: 37539726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Main RNA Methylation in Hepatocellular Carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine.
    Xu Y; Zhang M; Zhang Q; Yu X; Sun Z; He Y; Guo W
    Front Cell Dev Biol; 2021; 9():767668. PubMed ID: 34917614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-methyladenosine modification and metabolic reprogramming of digestive system malignancies.
    Cai X; Liang C; Zhang M; Xu Y; Weng Y; Li X; Yu W
    Cancer Lett; 2022 Sep; 544():215815. PubMed ID: 35798087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging roles of RNA methylation in gastrointestinal cancers.
    Xie S; Chen W; Chen K; Chang Y; Yang F; Lin A; Shu Q; Zhou T; Yan X
    Cancer Cell Int; 2020 Dec; 20(1):585. PubMed ID: 33372610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functions and mechanisms of post-translational modification in protein regulators of RNA methylation: Current status and future perspectives.
    Chen Y; Jiang Z; Yang Y; Zhang C; Liu H; Wan J
    Int J Biol Macromol; 2023 Dec; 253(Pt 2):126773. PubMed ID: 37690652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA methylation-related genes of m6A, m5C, and m1A predict prognosis and immunotherapy response in cervical cancer.
    Wang Y; Mao Y; Wang C; Jiang X; Tang Q; Wang L; Zhu J; Zhao M
    Ann Med; 2023 Dec; 55(1):2190618. PubMed ID: 37042849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma.
    Liu T; Sun L; Li ZZ; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P
    BMC Gastroenterol; 2023 May; 23(1):147. PubMed ID: 37170222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the m6A/m1A/m5C/m7G-related regulators on the prognosis and immune microenvironment of glioma by integrated analysis of scRNA-seq and bulk RNA-seq data.
    Yang L; Huang Z; Deng Y; Zhang X; Lv Z; Huang H; Sun Q; Liu H; Liang H; He B; Hu F
    J Gene Med; 2024 Feb; 26(2):e3666. PubMed ID: 38391150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy.
    Guo L; Yang H; Zhou C; Shi Y; Huang L; Zhang J
    Front Immunol; 2021; 12():773570. PubMed ID: 34956201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the regulatory role of RNA methylation modifications in glioma.
    Long S; Yan Y; Xu H; Wang L; Jiang J; Xu Z; Liu R; Zhou Q; Huang X; Chen J; Li Z; Wei W; Li X
    J Transl Med; 2023 Nov; 21(1):810. PubMed ID: 37964279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of m6A methylation modifications and tumor microenvironment infiltration in thyroid cancer.
    Ji FH; Yang Z; Sun C; Lowe S; Qiu XG
    Clin Transl Oncol; 2023 Jan; 25(1):269-282. PubMed ID: 36163443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of N6-methyladenosine modification on metabolic reprogramming in digestive tract tumors.
    Yu L; Gao Y; Bao Q; Xu M; Lu J; Du W
    Heliyon; 2024 Jan; 10(2):e24414. PubMed ID: 38293446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia.
    Ouyang X; Gong Y
    Front Immunol; 2022; 13():912526. PubMed ID: 35720276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Significance of N6-Methyladenosine RNA Methylation in Regulating the Hepatitis B Virus Life Cycle.
    Moon JS; Lee W; Cho YH; Kim Y; Kim GW
    J Microbiol Biotechnol; 2024 Feb; 34(2):233-239. PubMed ID: 37942519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value and immune landscapes of m1A/m5C/m6A-associated lncRNA signature in osteosarcoma.
    Wu ZY; Shi ZY
    Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5868-5883. PubMed ID: 36066162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration and validation of a combined Hypoxia and m6A/m5C/m1A regulated gene signature for prognosis prediction of liver cancer.
    Ren M; Fan B; Cao G; Zong R; Feng L; Sun H
    BMC Genomics; 2023 Dec; 24(1):776. PubMed ID: 38097948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.